NDC 42291-863

Lacosamide

Lacosamide

Lacosamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Lacosamide.

Product ID42291-863_e18102d6-764b-0a82-e053-2a95a90a85e0
NDC42291-863
Product TypeHuman Prescription Drug
Proprietary NameLacosamide
Generic NameLacosamide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-06-15
Marketing CategoryANDA /
Application NumberANDA204857
Labeler NameAvKARE
Substance NameLACOSAMIDE
Active Ingredient Strength200 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 42291-863-60

60 TABLET in 1 BOTTLE (42291-863-60)
Marketing Start Date2022-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lacosamide" or generic name "Lacosamide"

NDCBrand NameGeneric Name
63850-0055LacosamideLacosamide
63850-0053LacosamideLacosamide
63850-0054LacosamideLacosamide
63850-0056LacosamideLacosamide
65162-912LacosamideLacosamide
0131-1810Vimpatlacosamide
0131-2470Vimpatlacosamide
0131-2477Vimpatlacosamide
0131-2478Vimpatlacosamide
0131-2479Vimpatlacosamide
0131-2480Vimpatlacosamide

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.